Gaye Martin joined Nexelis as a Senior Director of Customer Solutions focused on delivering client centric solutions. Gaye brings with her over 30 years of industry experience spanning preclinical though clinical research with a concentration in bioanalysis. Gaye was 19 years with a global CRO where she focused on providing bioanalytical and drug metabolism solutions to global partners. Prior to becoming a Customer Solution specialist, Gaye spent over a decade running and supporting research projects at Merck Research Labs and at Bristol-Myers Squibb. Gaye’s scientific depth, attention to detail and commitment to her clients leads to individualized partner relationships.
Greg Kulnis joins Nexelis as a Senior Director of Customer Solutions with the goal of synchronizing the operation and commercial organizations to enhance the customer experience. He joins from a commercial role at Covance where he supported the global business development efforts for their Vaccine and Novel Immunotherapeutic Lab. Greg began his career in the Clinical Assay Research and Development group of Merck Research Labs where he supported the development of multiple licensed vaccines and the various assay methodologies needed to support that licensure. Greg also served as the Subject Matter Expert for Molecular Biology at PPD Vaccine and Biologics following the divestiture of the Wayne, PA labs to the PPD organization where he worked with various clients.
Jessette joined the business development team at Nexelis in 2018, bringing with her a background in nursing, clinical science and diagnostics. She serves as Senior Director of Business Development and is accountable for advancing and maximizing sales by identifying growth opportunities by applying a consultative and scientific sales approach. Jessette has over 20 years in the Life Sciences industry having held positions with Bay Area hospitals, Global CROs, diagnostic and specialty laboratory providers. Her comfort level extends from the emerging to global pharma and biotech client throughout the industry.
Prior to joining Pacific Biomarkers, Jessette worked at Clinipace Worldwide, a global contract research organization, as a Director of Business Development responsible for developing strategic partnerships in clinical development with emerging biotech and pharma. Before joining Clinipace, Jessette was a Director at Precision for Medicine, a specialized services organization, focused on diagnostic and medical device solutions.
She earned her Bachelors in Biology from San Francisco State University, where she was a member of the NIH Bridges Scholars Program for Biomedical and Behavioral Sciences.
Mark Sobolewski joined the customer solution team at Nexelis in 2019, bringing a background in nursing, clinical science and diagnostics. He serves as Senior Director of Customer Solutions and is accountable for sales on the East Coast of the United States utilizing a consultative scientific approach. Mark has over 25 years in the clinical trial industry having held positions in supporting the central laboratory and cardiac safety needs of his clients. His comfort level extends from the global pharma and biotech clients, as well as to emerging players. Prior to joining Nexelis, Mark worked at ICON Clinical Research (a global CRO), in the central laboratory division and eResearch Technology (cardiac safety), providing solutions to client clinical trials. He earned his Bachelor of Science in Nursing from Thomas Jefferson University with honors, and Bachelor of Arts from Rutgers University.
Tim Hynes joined Nexelis in 2016 and serves as Vice President of Business Development. In this capacity, he is responsible for managing all business development activities, oversees the business development executives as well as all marketing initiatives. Tim has over 30 years in the industry having held positions with global CROs, Central Laboratories and Contract Manufacturing Organizations. He most recently served with PPD Central Laboratories as a senior business development executive. His comfort level extends from the global pharma and biotech client as well as the emerging players so prevalent throughout the industry. He is well published and earned his BS degree from Southampton College, part of Long Island University, in Marine Science.